Volume Alert - ACHN 12.88 Achillion Pharmaceuticals $ACHN

New Post Public Reply Private Reply Replies (0) Message Board

Nov 12, 2014 at 12:04 PM

Volume Alert - ACHN 12.88 Achillion Pharmaceuticals $ACHN Hit a high today of 13.08 Closing the day 10:30 at 12.88 +0.40 +3.21% With a day low of 12.00 and a total volume of 2,379,091.

ACHN Recent Posts: http://investorshangout.com/Achillion-Pharmac...CHN-53213/

ACHN Achillion Pharmaceuticals Recent Headline News

Achillion Pharmaceuticals (ACHN) Stock Rises on Positive Hepatitis C Drug Results
at The Street - 6 mins ago
Shares of Achillion Pharmaceuticals (ACHN) continued to rise Wednesday after the company reported encouraging interim results from a Phase II study of its hepatitis C drug ACH-3102.
ACHN: 13.33 (+0.85)

Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Nov 12, 7:48AM CST
Companies like AbbVie (ABBV), Gilead (GILD) and Achillion (ACHN) had a strong presence at the annual Liver Meeting.
VRTX: 116.23 (-1.26), GILD: 106.77 (-1.24), ACHN: 13.33 (+0.85), DNDN: 0.17 (+0.02), AMGN: 162.31 (-0.11), ABBV: 63.84 (-0.01), REGN: 400.01 (+1.65)

This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success
Todd Campbell, The Motley Fool - Motley Fool - Wed Nov 12, 7:43AM CST
Source: Gilead Sciences. Developing drugs that help established blockbusters work better is a major trend in biotechnology. It's a lower-stakes game because drug developers only need to show that their products can improve upon existing therapies,...
GILD: 106.77 (-1.24), ACHN: 13.33 (+0.85), MRK: 59.29 (-0.08)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ICUI: 83.15 (+2.28), OREX: 6.05 (+1.01), PCMI: 8.78 (-0.12), CYAN: 6.04 (-0.02), ACHN: 13.33 (+0.85), TGTX: 13.24 (+0.33), AGIO: 87.84 (+5.93), LIOX: 5.36 (-0.07), SAJA: 6.25 (+0.65), PLNR: 6.97 (+0.16)

Most active Nasdaq-traded stocks
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
FB: 73.92 (-0.69), ACHN: 13.33 (+0.85), DNDN: 0.17 (+0.02), CMCSK: 53.45 (+0.67), ARCP: 8.66 (unch), ZNGA: 2.81 (+0.06), MSFT: 48.79 (-0.08), INTC: 33.31 (unch), GRPN: 8.13 (+0.33), CMCSA: 53.59 (+0.63), AAPL: 110.88 (+1.18), CSCO: 25.04 (-0.11)

Achillion Jumps on Encouraging Data on its HCV Candidate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 4:10PM CST
Shares of Achillion Pharmaceuticals (ACHN) soared over 27% after the company reported encouraging interim results on ACH-3102.
JNJ: 108.87 (-0.04), GILD: 106.75 (-1.26), ACHN: 13.33 (+0.85), AMAG: 34.83 (-0.05)

Why Is Gilead Always Holding The Ace? A Prediction Of The Future HCV Market And What Analysts Aren't Talking About
Pharma Doc - Seeking Alpha - Tue Nov 11, 10:13AM CST
No matter when you've followed Gilead (NASDAQ: GILD ) over the past decade, they always seem to be holding the ace. Whether in the HIV arena or now in HCV, the Gilead management is always one step ahead and is planning to dominate its market. Gilead...
GILD: 106.75 (-1.26), ACHN: 13.33 (+0.85), MRK: 59.29 (-0.08), ABBV: 63.84 (-0.01), BMY: 58.75 (+0.03)

Gilead presents Harvoni data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:03AM CST

JNJ: 108.87 (-0.04), GILD: 106.75 (-1.26), ACHN: 13.33 (+0.85), CNAT: 7.03 (-0.03), MRK: 59.29 (-0.08), RGLS: 20.02 (-0.45), ABBV: 63.84 (-0.01), BMY: 58.75 (+0.03), ENTA: 43.27 (+0.05)

AbbVie presents HCV/HIV and liver transplant HCV data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 9:07AM CST

JNJ: 108.87 (-0.04), GILD: 106.77 (-1.24), ACHN: 13.34 (+0.86), CNAT: 7.03 (-0.03), MRK: 59.29 (-0.08), RGLS: 20.02 (-0.45), ABBV: 63.84 (-0.01), BMY: 58.75 (+0.03), ENTA: 43.27 (+0.05)

Merck presents data from its investigational HCV combo
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:37AM CST

JNJ: 108.87 (-0.04), GILD: 106.76 (-1.25), ACHN: 13.34 (+0.86), CNAT: 7.03 (-0.03), MRK: 59.29 (-0.08), LGND: 57.02 (+0.12), RGLS: 20.02 (-0.45), ABBV: 63.84 (-0.01), BMY: 58.75 (+0.03), ENTA: 43.27 (+0.05)

Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Nov 11, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for ACHN, CLDX, KNDI, ILMN and AMD.
KNDI: 14.97 (-0.74), AMD: 2.69 (-0.04), ACHN: 13.34 (+0.86), CLDX: 14.65 (+0.19), ILMN: 187.86 (-0.18)

Gilead presents data from three HCV drug combo studies
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:05AM CST

JNJ: 108.87 (-0.04), GILD: 106.76 (-1.25), ACHN: 13.34 (+0.86), CNAT: 7.03 (-0.03), LGND: 57.02 (+0.12), RGLS: 20.02 (-0.45), ABBV: 63.84 (-0.01), BMY: 58.75 (+0.03), ENTA: 43.27 (+0.05)

Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:44AM CST
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares surge a little over 27% on the day
HSKA: 15.96 (-0.18), ACHN: 13.34 (+0.86), ILMN: 187.86 (-0.18), AFFX: 9.49 (+0.07)

Achillion rises on new hepatitis C drug study
AP - Mon Nov 10, 1:17PM CST
NEW YORK (AP) — Shares of Achillion Pharmaceuticals climbed Monday after the company reported clinical trial results for one of its experimental hepatitis C drugs.
GILD: 106.76 (-1.25), ACHN: 13.34 (+0.86)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 11:59AM CST

UCP: 11.47 (-0.23), JRJC: 7.38 (-0.11), NAVB: 1.02 (unch), SANW: 3.41 (-0.10), PLPM: 1.68 (-0.07), RYN: 26.31 (-0.42), INFU: 2.93 (unch), LIOX: 5.36 (-0.07), DY: 27.52 (-0.67), MTZ: 24.46 (-0.35), CGIX: 6.46 (-0.04), MUX: 1.33 (-0.01), OREX: 6.05 (+1.01), URRE: 2.47 (-0.04), ACHN: 13.34 (+0.86), REN: 2.57 (-0.13), MPO: 3.19 (+0.05), AKBA: 11.04 (+0.68), TRX: 1.05 (-0.01), PLNR: 6.97 (+0.16)

Achillion up on HCV data
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:30AM CST

ACHN: 13.34 (+0.86)

Merck Down On Hepatitis C Data; Gilead Rises
at Investor's Business Daily - Mon Nov 10, 10:14AM CST
Big pharma Merck (MRK) was down nearly 2% on the stock market today after the latest data from its hepatitis C pipeline underwhelmed the Street. On Sunday at the annual conference of the American Association for the Study of Liver Disease, Merck...
JNJ: 108.84 (-0.07), GILD: 106.77 (-1.24), ACHN: 13.34 (+0.86), MRK: 59.29 (-0.08), ABBV: 63.84 (-0.01), BMY: 58.75 (+0.03)

Buyside Buzz on Gilead, Regulus From This Year's Liver Meeting
at The Street - Mon Nov 10, 9:40AM CST
Here's a quick sketch of the Wall Street gossip mill emerging from the 'Liver Meeting.'
GILD: 106.77 (-1.24), ACHN: 13.34 (+0.86), RGLS: 20.02 (-0.45), ABBV: 63.84 (-0.01)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating AI's New Era: Dresner's 2026 Findings

Big Insights in the AI World of 2026 Well folks, if there's one thing making waves in the boardrooms this year, it's AI. Dresner Advisory Services just threw down a gauntlet for companies with their fresh batch of reports focused on the dizzying world of AI. They ripped right into it, exploring how firms can bag a heap of benefits and deal with the hurdles that come with...

Castillo Engineering Gears Up with New VP Appointments

New Leadership to Drive Expansion In a boost to its commitment to scaling up, Castillo Engineering, based in Maitland, Florida, has roped in two veterans from the renewables sector as vice presidents. Aaron Carrillo and Devin Radovich, who share a history of successful collaboration at Renewable Energy Systems Americas (RES), are set to guide Castillo's growth in the...

Annex Brands Grows with Bastrop's PostalAnnex Opening

New PostalAnnex Location Opens in Bastrop, TX Here's a fresh chapter in the books for Annex Brands, Inc. They've just cut the ribbon on a brand spanking new PostalAnnex in Bastrop, Texas, handing the reins over to eager fresh faces, Chetan Modi and Karan Desai. And you know what? This ain't just any regular location. It's a one-stop-shop for anything you could need, from...

Molex's VersaBeam Mini Pushes AI Data Center Limits

Game-Changer for AI Data Centers? Across the tech landscape, space is a premium, and Molex's new VersaBeam Mini arrives like a hail Mary in the fourth quarter. In AI data centers, squeezing down every single component counts—especially when optical density's in play. What we're seeing here is a potential paradigm shift. A 3x density improvement from a tiny 3.5 x 9 mm...

Tenera Care's Tech Triumph: Halving Falls with Simplicity

Every once in a while, a piece of tech comes along that makes you sit up and say, ‘Now that’s a game-changer!’ And with the recent rave reviews, Tenera Care seems to hit just that sweet spot for folks in the senior living game. By handing Dublin Glenn Memory Care the gold in the KISS category at the 2026 McKnight's Technology Awards, it’s clear the industry is...

HNTB Expands in Capital Region: A Strategic Move

Breaking New Ground in Arlington and Baltimore Deepening their stake in the Capital Region's future, HNTB has thrown open new office doors in Arlington, Virginia, and Baltimore, Maryland. We're not just talking fancy buildings, folks—this is about securing a piece of the infrastructure pie that's only going to get bigger and tastier. Infrastructure's the backbone of...

U.N. Leaders Converge at NYSE, Forus Soars to $3B Valuation

A Busy Morning at the NYSE with Key Guests and Global Events In a world where high-stakes diplomacy and roaring market bells go hand in hand, today brings the U.S. Secretary of State, Marco Rubio, to the New York Stock Exchange. With the 81st Session of the United Nations General Assembly shaking up the Big Apple, the city finds itself at the intersection of politics and...

NACD Honors Top Board Leaders with 2026 Awards

Celebrating Boardroom Mavericks at NACD Gala September 2026 has brought some sparkling recognition to the elites guiding today's corporate governance landscapes. The National Association of Corporate Directors (NACD) has announced their Directorship 100 honorees, tipping their hats to stellar individuals firing on all cylinders in the boardroom. Who's Getting the Nod?...

Lititz Mutual Embraces AI with Guidewire ProNavigator

It's not every day you see a company like Lititz Mutual making moves in the artificial intelligence (AI) arena. Based out of Lititz, Pennsylvania, this insurance firm has decided to shake things up with Guidewire's ProNavigator AI assistant. Forging New Paths in Insurance Lititz Mutual is set to inject some serious tech into their operations. The goal? Make life easier...

Anixa Expands Global Footprint with Aussie Patent

Breaking New Ground in Cancer Immunotherapy Today feels like a pivotal day for Anixa Biosciences. Their announcement about securing a patent in Australia for their trailblazing breast cancer vaccine is like planting a flag on new, promising territory. This is no minor step; it's a strategic leap for the company as it strengthens its intellectual grip on the global...